a Randomized Controlled Trial Comparing Medical and Medical-surgical Treatment in Diabetic Foot Osteomyelitis (DIPIOS)
Primary Purpose
Diabetic Foot
Status
Withdrawn
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
Medical/surgical treatment versus medical treatment
Sponsored by
About this trial
This is an interventional treatment trial for Diabetic Foot focused on measuring diabetic foot, osteomyelitis
Eligibility Criteria
Inclusion Criteria:
- diabetes
- neuropathy and a forefoot ulcer
- osteomyelitis on X ray involving one or two contiguous ray
- confirmed osteomyelitis on bone biopsy if a metatarsal head is involved
- palpable distal pulses
Exclusion Criteria:
- glomerular filtration rate < 30ml/min
- whole bone destruction
- contra-indication for off loading
- ASAT or ALAT > three times normal rate
- immunosuppressive drugs
- Charcot foot on the concerned foot
- pregnancy
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
1
Arm Description
Outcomes
Primary Outcome Measures
no osteomyelitis spreading and wound healing and no osteomyelitis relapse 12 months after wound healing
Secondary Outcome Measures
amputation rate
healing time
ulcer relapse 12 months after healing
Full Information
NCT ID
NCT00578890
First Posted
December 19, 2007
Last Updated
September 14, 2012
Sponsor
Assistance Publique - Hôpitaux de Paris
1. Study Identification
Unique Protocol Identification Number
NCT00578890
Brief Title
a Randomized Controlled Trial Comparing Medical and Medical-surgical Treatment in Diabetic Foot Osteomyelitis
Acronym
DIPIOS
Official Title
Comparison of Medical and Medical-surgical Management of Diabetic Foot Osteomyelitis
Study Type
Interventional
2. Study Status
Record Verification Date
June 2011
Overall Recruitment Status
Withdrawn
Why Stopped
not enough recruitment
Study Start Date
June 2008 (undefined)
Primary Completion Date
June 2011 (Anticipated)
Study Completion Date
June 2011 (Anticipated)
3. Sponsor/Collaborators
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Osteomyelitis is a frequent complication of diabetic foot ulcer. Several therapeutic strategies are used : medical treatment with antibiotics and foot offloading or surgical treatment consisting in the resection of infected bone and a shorter antibiotic course. The medical treatment risk is a longer healing time and a risk of bone infection relapse. The surgical treatment risk is the ulcer relapse because of the modification of the foot structure. These treatments need to be compared in terms of benefit/risk ratio. Our hypothesis is : 1) in the medical treatment group a 7 month mean healing time of and a 15% osteomyelitis recurrence rate;2) in the medical-surgical treatment group a 4 month mean healing time and a 10% osteomyelitis recurrence rate.
Detailed Description
The study aim is to compare the rate of therapeutic success of the secondary ostéite with a wound of the foot diabetic, obtained either by a single medical coverage(care), or by a medical surgical coverage(care). The therapeutic success being defined by the association of 1) the absence of local distribution(broadcasting) of the ostéite 2) the healing of the wound 3) in 12 months of the healing the absence of local recurrence of the ostéite
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetic Foot
Keywords
diabetic foot, osteomyelitis
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Type
Experimental
Intervention Type
Procedure
Intervention Name(s)
Medical/surgical treatment versus medical treatment
Intervention Description
A 12 week course antibiotics versus a limited resection of infected bone associated with a 4 week course antibiotics.
Primary Outcome Measure Information:
Title
no osteomyelitis spreading and wound healing and no osteomyelitis relapse 12 months after wound healing
Time Frame
12 months after healing
Secondary Outcome Measure Information:
Title
amputation rate
Time Frame
before healing
Title
healing time
Time Frame
end of study
Title
ulcer relapse 12 months after healing
Time Frame
12 months after healing
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
diabetes
neuropathy and a forefoot ulcer
osteomyelitis on X ray involving one or two contiguous ray
confirmed osteomyelitis on bone biopsy if a metatarsal head is involved
palpable distal pulses
Exclusion Criteria:
glomerular filtration rate < 30ml/min
whole bone destruction
contra-indication for off loading
ASAT or ALAT > three times normal rate
immunosuppressive drugs
Charcot foot on the concerned foot
pregnancy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Agnès Hartemann-Heurtier, PHD
Organizational Affiliation
Assistance Publique - Hôpitaux de Paris
Official's Role
Principal Investigator
12. IPD Sharing Statement
Learn more about this trial
a Randomized Controlled Trial Comparing Medical and Medical-surgical Treatment in Diabetic Foot Osteomyelitis
We'll reach out to this number within 24 hrs